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ABSTRACT
The ongoing opioid epidemic in West Virginia has given rise to a unique population
of opioid-addicted obstetric patients. Appropriate education, counseling, and
implementation of contraception is of extreme importance among this high-risk
patient population. This study was a retrospective chart review aimed at evaluating
contraception choice and initiation rates among patients enrolled in a maternal
buprenorphine maintenance program compared to non-opioid addicted patients. Rates
of planned contraception initiation were compared between the two groups. Rates of
actual contraception initiation were also compared. Contraceptive choices were then
placed into one of three tiers based on efficacy, and rates of initiation of equivalent,
less effective, or more effective methods of contraception were compared between
the groups. Rates of compliance to planned contraceptive method were low for both
groups and not statistically different between the two. Use of long acting reversible
contraceptives was statistically higher among the control population. Compared to
the control group, a significant number of women in the opioid group received less
effective contraception than planned. This study shows that the high-risk population of
opioid addicted patients did not receive high efficacy, long lasting contraception at the
same rate as their non-opioid addicted peers.
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INTRODUCTION
As of 2015, West Virginia led the nation in the rate
of opioid overdose deaths at 41.5 per 100,000.1 This
rate is more than two times the national average, and
33 percent greater than the two next closest states,
Kentucky and Ohio.1 As rates of opioid abuse and
overdose continue to climb across the nation and
within West Virginia, a high risk obstetric population
of opioid abusers has emerged presenting several
unique problems involving pre-conception,
antepartum, postpartum, and neonatal care. The
prevalence of unintended pregnancies is significantly
increased from 31-47% for the general population to
84% among opioid abusers.2 This high-risk population
is also at increased risk for rapid repeat pregnancy.
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Babies born to mothers using or abusing opioids are
at risk for Neonatal Abstinence Syndrome (NAS), a
drug withdrawal syndrome that presents after birth.3
When taken together, these issues make simple,
affordable, reliable contraception methods a priority
among opioid abusers.
Contraception can be provided inpatient following
a delivery or during the postpartum visit. The
American College of Obstetrics and Gynecology
(ACOG) currently recommends a postpartum visit
for uncomplicated pregnancies between four and
six weeks,4 however, 10-40% of women do not
attend their postpartum visits.5 Risk factors for
non-compliance with postpartum visits include
lower levels of education, no prenatal care, and low

mds.marshall.edu/mjm
© 2022 Marshall Journal of Medicine

Marshall Journal of Medicine
Volume 5 Issue 1

income.6 If women miss this visit and do not receive
further counseling regarding contraceptive options
or implementation, they are at significant risk for
unintended pregnancy.
The type of contraceptive method also is important
in preventing unintended pregnancies. Compared to
other forms of contraception, long acting reversible
contraceptive (LARC) methods do not require
significant user effort to be effective.7 There is an 87%
continuation rate among LARC users, compared to
57% continuation among short-acting contraception
users, and LARC users have higher overall satisfaction
with their choice of contraception.8 The efficacy
of LARC methods is also comparable to surgical
sterilization methods such as bilateral tubal ligation
(BTL) or vasectomy.7 For patients desiring any form of
contraception, assuring accessibility is paramount.
The goal of this study was to assess postpartum
contraceptive method choice and compliance,
postpartum follow up and incidence of rapid repeat
pregnancy among high risk addicted pregnant
patients at Marshall University School of Medicine
Department of Obstetrics and Gynecology Outpatient
Center.
METHODS
This study was a retrospective chart review evaluating
contraception choice and initiation rates among
patients enrolled in a maternal buprenorphine
maintenance program compared to non-opioid
addicted patients. The Maternal Addiction and
Recovery Center (MARC) is an opioid replacement
program for high risk opioid addicted pregnant
patients. This program is comprised of low income,
low educational attainment opioid addicted patients.
This group was compared to the general patient
population within the residents’ outpatient clinic at
the same academic institution. We defined the study
population as those patients actively enrolled into the
MARC program for their obstetric care from 2010-14.
We defined the control population as those patients
following with the OB/GYN resident clinic at the same
institution for obstetric care during that same time
period. Retrospective chart review evaluated patient
contraceptive choice prior to delivery as documented
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in the prenatal record, actual contraception initiated
following delivery, and compliance or successful
implementation of contraception within six weeks
of delivery. Follow up at the six week postpartum
visit was also recorded. Additional data included age,
race, gravidity, parity, mode of delivery, smoking
status, and history of sexually transmitted disease.
The study period was chosen to allow a year of
follow up after delivery to also assess rates of rapid
repeat pregnancy (defined as repeat pregnancy
within one year of delivery).
Contraceptive methods offered by the institution
included bilateral tubal ligation (BTL), vasectomy,
intrauterine device (IUD), subdermal implant,
depomedroxyprogesterone acetate (DMPA), oral
contraceptive pill, transdermal patch, ring, and
condoms. Subjects undecided or who did not
desire contraception were classified as such. For
comparison purposes, methods were grouped
according to efficacy. LARC methods and sterilization
methods were grouped as Tier 1 efficacy, the pill,
patch, ring, DMPA were grouped as Tier 2, and
condoms, undecided and none were grouped as Tier
3 efficacy.
Contraceptive use, follow up, rapid repeat pregnancy
rates and changes in contraceptive efficacy (from
what was planned to what was actually given) were
compared between the MARC subjects and resident
clinic subjects. Statistical analysis was completed
using Small Stata 14.2. Continuous variables were
analyzed using t-test and categorical variables
were analyzed by chi square or Fisher’s exact test.
Institutional review board was obtained prior to
study commencement.
RESULTS
There were a total of 207 subjects included in the
study. The MARC group included 61 patients, while
the resident clinic (RC) included 146 patients. Table
1 shows basic demographic information between
the two groups. There was no difference in groups
among age, race, mode of delivery or other sexually
transmitted diseases. The MARC group had a
statistically higher prevalence of subjects covered by
Medicaid, subjects who were smokers, and subjects
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TABLE 1. Missing Values not included in percentages.
Number of patients who reported their insurance.

A

TABLE 2: Planned versus actual contraception by method among MARC and Resident Clinic (RC)
patients.

with Hepatitis C.
Table 2 demonstrates planned contraception for
each subject group by method and the number of
those subjects who ended up actually receiving
the method they planned. The most frequent
planned contraceptives among the MARC group
and RC group were BTL and Undecided. Twenty
eight subjects in the MARC group (45.9%) and 90
subjects in the RC group (61.6%) actually received
the contraceptive they had initially planned in their
MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

prenatal record, p= 0.037. Only 13 of 23 (56.5%)
MARC subjects and 20 of 30 (66.7%) RC subjects
received a desired BTL. There were very few women
in the MARC program planning an IUD or implant for
postpartum contraception.
Table 3 compares the planned contraception for
each subject group by method to the total number
of subjects who received each method. The
highest frequency method for both groups was no
contraception (28 MARC subjects, 45.9% vs 46 RC
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TABLE 3: Overall actual contraception by method among MARC and Resident clinic
patients.

FIGURE 1. Comparison of planned versus actual contraception by efficacy tiers. RC is resident clinic, MARC maternal addiction recovery center. Tier 1 MARC 18.0% drop/Tier 1 RC 5.5% drop. Tier 2 MARC 6.6% increase /Tier 2 RC
5.5% increase. Tier 3 MARC 9.8% increase/Tier 3 3.3% increase.
*denotes statistical significance.

subjects, 31.5%, p=0.04). There were three additional
women in the MARC group that ended up receiving
a BTL that had not initially planned this method in
their prenatal record. More women in the RC group
received LARC options for contraception compared
to those within the MARC group.
Groups were compared by subjects who received
higher or lower efficacy methods. In the MARC
subjects, 17 (27.8%) changed to a lower efficacy
method from planned Tier1 method to actual tier 2
or 3 method, while in the resident clinic this number
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was 27 subjects (18.5%), p=0.13. There were only
9 (14.7%) MARC subjects and 26 (17.8%) resident
clinic subjects that raised in contraceptive efficacy
from planned Tier 2/3 to actual Tier 1, p= 0.59. Of
the 53 total subjects that wanted a tubal ligation,
33 (62.2%) received a tubal ligation and 4 (7.5%)
received an IUD. The remaining 16 subjects received
a lower tier efficacy method. The most common
choice of contraception, when subjects lowered in
efficacy, was to receive no contraceptive (86.4%).
When choosing a higher efficacy, subjects most
commonly (51.4%) went from originally wanting no
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contraceptive to receiving pills/patch/ring/depo/
condoms.
Figure 1 demonstrates the proportion of both groups
desiring Tier 1, Tier 2 and Tier 3 methods, and the
proportion receiving these methods by efficacy. The
greatest change between groups is demonstrated
with Tier 1 methods (IUD, implant, BTL and
vasectomy), with a greater proportion of the MARC
group not receiving one of these methods.
Overall, a total of 15 patients were pregnant within
1 year after birth; 4 (6.6%) were in the MARC group
and 11 (7.5%) were in the resident clinic group,
p= 0.37. None of the patients pregnant within a
year were using Tier 1 contraceptive methods. 146
total patients (70.5%) followed up at the six-week
postpartum visit, with 32 (52.5%) of these in the
MARC group and 114 (78.1%) in the resident clinic
group, p=<.0.001. Of those who did not show for
their postpartum visit, only one subject was using a
tier 1 method of contraception.
DISCUSSION
This study demonstrates that a large proportion
of patients will change their minds regarding their
desired contraception methods, and some may
choose less effective forms of contraception. Nearly
half of the MARC population (45.9%), regardless
of planned contraception method, received no
contraception postpartum. This may be attributable
to shortcomings in counseling, or to the significant
percentage loss to follow up among MARC patients.
This finding is consistent with other studies showing
low rates of contraceptive use among women in
opioid treatment programs. One study demonstrated
that among women not desiring pregnancy, only
55% were using any contraception.9 Another study
demonstrated less contraceptive pill use (4% vs 25%)
and IUD use (1% vs 6%) when comparing opioid
addicted women to controls.10
In the current study, overall number of women
choosing LARCs was low between both groups, yet
the RC population chose LARC’s significantly more
frequently than the MARC population. It is unclear
based on the scope of this study if this is due to a
lack of counseling or other barriers. This finding is
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consistent with other studies demonstrating low
use of LARCs among opioid addicted patients from
5-13%.9,11
Reasons for patient changes in contraceptive
methods might include misinformation, mistrust in
health care services, lack of appropriate counseling,
or cost. Other barriers affect access from a systems
level, such as access to BTL or LARC methods. In our
study only 56.5% of MARC patients received a BTL
when desired. A majority of the MARC population
and a significant portion of the RC population
were Medicaid patients. In West Virginia, Medicaid
patients must be over 21 years old, be medically
competent, and have signed a state BTL consent
form 30 days in advance but not more than 180 days
in advance of delivery if they want their sterilization
procedure covered. There is an emergent delivery/
abdominal surgery clause under which WV Medicaid
will cover the procedure, however the time from
consent to the time of delivery/surgery must be 72
hours. These stipulations may deter patients from
pursuing sterilization as a means of contraception,
or, in the event of a truly emergent delivery, prevent
them from receiving a sterilization altogether.
Operating room and provider availability are
further barriers to obtaining a BTL for contraceptive
purposes. Often there are multiple procedures
scheduled in the labor and delivery operating rooms
and those patients desiring BTL after a vaginal
delivery frequently get “bumped” on the schedule to
make room for more pressing operations. Given the
findings of the study, it is important for hospitals and
physicians to improve access to BTL.
At the time of this study patients who desired LARC
were required to attend a postpartum visit to obtain
their contraceptive implant or IUD. For women with
limited resources this can be an additional barrier
to receiving effective contraception. In 2016, the
year immediately following the timeframe for data
collection in this study, WV Medicaid began covering
and reimbursing immediate postpartum (IPP) LARC
provision. Future study should include the impact
of this policy on uptake and compliance of LARCs
among opioid addicted patients.
Several limitations exist in this study. As a
retrospective chart review, the data is limited by
accurate medical records. Among patients that did
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not keep postpartum follow up it was impossible to
determine if they pursued any form of contraception
with another provider. Another limitation is using the
resident clinic patients as a control group. While this
group was chosen as the most likely demographically
similar group to the MARC patients, there are some
obvious differences. More patients in the MARC
program had Medicaid insurance, and this study
did not evaluate income or educational attainment.
However, comparing the MARC group to any control
group helps to delineate any disparities specific to
these patients.
The results of this study show that continued efforts
must be made to appropriately educate and counsel
the obstetric population of West Virginia regarding
contraception. Special efforts must also be made to
ensure that the ever-growing, high-risk population
of opioid users are adequately counseled on their
options for contraception. Obstetric providers must
continue to educate patients on the safety, efficacy,
and ease of use related to LARC methods as these
methods become more easily available immediately
postpartum. Providers can frontload their counseling
during prenatal visits and steer the discussion toward
high efficacy, low effort contraceptive methods.
Future study should include effective messaging
about contraception specific to opioid addicted
patients, and the impact of formal contraception
curriculums developed within treatment programs.
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